Results 151 to 160 of about 2,948 (168)

[Cardiovascular safety of vardenafil].

Zhonghua nan ke xue = National journal of andrology, 2007
Vardenafil is a new type of PDE5 inhibitor (PDE5I) with great inhibiting potential on PDE5 (IC50: 0.01 nmol/L) for enhancing erectile function. International and domestic clinical studies showed it to be safe and effective in treating ED with mild temporary side effects such as headache, dizziness, flushing and rhinitis.
openaire   +1 more source

Vardenafil

Drugs, 2012
Lesley J Scott, Scott Lesley J
exaly  

[Molecular studies of vardenafil].

Zhonghua nan ke xue = National journal of andrology, 2007
The remarkable therapeutic success of PDE5 inhibitors in the treatment of male erectile dysfunction has focused the attention of the researchers on better defining the properties of the individual inhibitors and PDE5 that contribute to the high affinity of these inhibitors for interaction with the PDE5 catalytic site.
openaire   +1 more source

Pharmacokinetics of a New Orodispersible Tablet Formulation of Vardenafil

Clinical Drug Investigation, 2012
Roland Heinig
exaly  

Vardenafil

2017
openaire   +1 more source

Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)

Neurochemistry International, 2004
Jackie D Corbin, Alfreda Beasley, Mitsi A Blount   +2 more
exaly  

The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension

Cardiovascular Research, 2013
Xin Jiang, Ping Yuan, Zhi-Cheng Jing
exaly  

Identification of a novel vardenafil analogue in herbal product

Journal of Pharmaceutical and Biomedical Analysis, 2008
Wing-Tat Poon, Chi-Kong Lai, Albert Yan-Wo Chan   +2 more
exaly  

Results of Vardenafil Mediated Power Doppler Ultrasound, Contrast Enhanced Ultrasound and Systematic Random Biopsies to Detect Prostate Cancer

Journal of Urology, 2011
Girolamo Morelli, Marco Paterni, Davide Caramella   +2 more
exaly  

Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction

International Journal of Clinical Practice, 2004
C Stief, Hartmut Porst, I Saenz de Tejada   +2 more
exaly